Representatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have.
Maggie L. Shaw
Advertisement
Articles by Maggie L. Shaw
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Starting from scratch on neovascular age-related macular degeneration
2
Q&A: Insights from Rajesh K. Rajpal, MD, on an incision-free keratoconus therapy
3
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
4
Rethinking punctal occlusion as an option for allergic conjunctivitis
5
.png "Optometry Times"){kind=logo}
